RCT of Modified Qing Fei Pai Du Tang (mQFPD) for COVID-19

Summary

This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate a 21-herb formula named modified Qing Fei Pai Du Tang (mQFPD) to treat COVID-19-positive outpatients with mild-to-moderate symptoms assigned to self-quarantined and home management. This the study aims to establish the safety and feasibility of the use of mQFPD vs placebo in 66 total subjects. Subsequent trials will evaluate other therapeutics as well as the efficacy of mQFPD in a larger study population.

Timeline

Start

2021-07-01

Primary completion

2022-01-27

Completion

2022-03-13

Outcome

Missed primary endpoint

registry analysis (superiority test); Modified Qing Fei Pei Du Tang vs Placebo; p = 1.000; ratio of frequencies 0.000; Chi-squared, Corrected NCT04939415 ↗

Drugs

Indications